UNSPSC 51384606: Bisfenazone

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C25H29N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3OA32ZIB31, chemically known as 3-(((2,3-dimethyl-5-oxo-1-phenyl-3-pyrzolin-4-yl)amino)methyl)-4-isopropyl-2-methyl-1-phenyl-3-pyrazolin-5-one but generally known as bisfenazone, which bears US NIH Compound Identifier 189866. European Medicines Agency schedules Bisfenazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05851MIG.

UNSPSC 51384606 Bisfenazone, a Commodity code, does not align with the recent state and local solicitation activity tagged under it. The single recent opportunity on record—Seminole County, Florida's IFB60459723LAS, posted June 30, 2026—seeks procurement of naloxone and safe drug deactivation systems for community health initiatives, a scope that falls outside the nominal chemical classification of bisfenazone. The mismatch suggests either a tagging error in the source data or a misalignment between the code's formal definition and how the issuing body categorized the purchase.

Seminole County's IFB called for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The response deadline was July 26, 2023, and the contract included a two-year initial term with a one-year renewal option, fixed-fee pricing, and standard compliance requirements including drug-free workplace certification and E-Verify authorization. The procurement offered no explicit set-aside designations. Given the single opportunity and its subject-matter divergence from the code's nominal scope, activity under UNSPSC 51384606 appears minimal for state and local government procurement purposes.